Find Out Our
Latest Articles

Did you know that as of February 2026, the FDA’s Quality Management System Regulation now mandates direct harmonization with ISO 13485, granting…

A medical device prototype that performs flawlessly in a controlled lab environment often becomes a liability when it reaches the assembly floor. If…

Biocompatibility is not a static property of a medical grade material; it is the cumulative result of every process, chemical, and environmental…

The “valley of death” between a successful prototype and scalable mass production claims nearly half of all medtech innovations before they reach a…

In 2026, the traditional boundary between logistics and engineering has vanished, making medical device supply chain management a high-stakes…

In 2024, device failure officially surpassed manufacturing defects as the primary cause of medical device recalls, accounting for 11.1% of all…

While many view a sterile environment as a mere regulatory hurdle, the reality is that cleanroom validation for medical device manufacturing…

In the first half of 2026, the United States saw 313.1 million medical device units recalled, which represents a staggering 516.8 percent increase…

Through June 2026, the average time to receive an FDA decision on a 510(k) submission rose to 155.9 days, a 5.2% increase that underscores the…

In 2026, 81% of medical device manufacturers report that their validation workloads are steadily increasing. This surge isn’t just a byproduct of…

In early 2026, 71% of FDA 483 observations cited incomplete Design and Development Files, highlighting a systemic failure in the medical device…

A flawless prototype is a liability if it cannot be replicated at scale under the rigorous requirements of the FDA Quality Management System…